MACCIONI, ANNA MARIA
 Distribuzione geografica
Continente #
EU - Europa 133.526
NA - Nord America 7.046
AS - Asia 2.660
SA - Sud America 347
Continente sconosciuto - Info sul continente non disponibili 213
AF - Africa 45
OC - Oceania 6
Totale 143.843
Nazione #
IT - Italia 131.373
US - Stati Uniti d'America 6.912
CN - Cina 1.067
SG - Singapore 924
UA - Ucraina 565
SE - Svezia 411
DE - Germania 351
BR - Brasile 284
GB - Regno Unito 189
FI - Finlandia 186
FR - Francia 185
VN - Vietnam 152
IN - India 101
NL - Olanda 88
HK - Hong Kong 87
KR - Corea 75
CA - Canada 73
BD - Bangladesh 51
PL - Polonia 28
ES - Italia 25
IR - Iran 25
ID - Indonesia 22
JP - Giappone 21
AR - Argentina 20
RU - Federazione Russa 20
BE - Belgio 19
PK - Pakistan 19
TR - Turchia 19
MX - Messico 18
CO - Colombia 17
IQ - Iraq 16
VG - Isole Vergini Britanniche 16
SA - Arabia Saudita 14
AT - Austria 11
CH - Svizzera 11
TW - Taiwan 11
IL - Israele 10
MA - Marocco 10
EC - Ecuador 9
PT - Portogallo 9
UZ - Uzbekistan 9
ZA - Sudafrica 9
CZ - Repubblica Ceca 7
AU - Australia 6
CL - Cile 6
DK - Danimarca 6
JM - Giamaica 6
PH - Filippine 6
TH - Thailandia 6
IE - Irlanda 5
KE - Kenya 5
TN - Tunisia 5
UY - Uruguay 5
CR - Costa Rica 4
EG - Egitto 4
LT - Lituania 4
RO - Romania 4
VE - Venezuela 4
AL - Albania 3
BG - Bulgaria 3
DZ - Algeria 3
EE - Estonia 3
GR - Grecia 3
GT - Guatemala 3
HU - Ungheria 3
LU - Lussemburgo 3
MU - Mauritius 3
OM - Oman 3
RS - Serbia 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
ET - Etiopia 2
HN - Honduras 2
JO - Giordania 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
MY - Malesia 2
NI - Nicaragua 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
PS - Palestinian Territory 2
AZ - Azerbaigian 1
BB - Barbados 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
GE - Georgia 1
IS - Islanda 1
KW - Kuwait 1
MD - Moldavia 1
MM - Myanmar 1
MW - Malawi 1
PE - Perù 1
PR - Porto Rico 1
PY - Paraguay 1
Totale 143.627
Città #
Cagliari 127.427
Uta 1.954
Ashburn 1.097
Chandler 508
Singapore 503
San Jose 482
Fairfield 393
Woodbridge 359
Jacksonville 310
Ann Arbor 303
Houston 299
Nyköping 287
Boardman 277
Dallas 250
Beijing 248
Wilmington 181
Seattle 147
Dearborn 140
Cambridge 130
Milan 122
Los Angeles 120
Santa Clara 105
Helsinki 101
Hefei 100
Nanjing 96
Rome 81
Hong Kong 77
Boston 76
Council Bluffs 71
Lauterbourg 69
Seoul 69
Shanghai 66
New York 60
Naples 54
São Paulo 51
Buffalo 49
Ho Chi Minh City 47
Redwood City 46
Toronto 43
Shenyang 40
The Dalles 39
Chicago 33
Guangzhou 33
Hanoi 28
Frankfurt am Main 27
Verona 27
Mountain View 26
Hebei 25
Padova 25
Bari 24
Bologna 24
Catania 24
Changsha 24
Florence 24
Munich 24
Orem 23
Chennai 22
Nanchang 22
Turin 22
Jiaxing 20
Tianjin 20
Jinan 19
Sassari 19
Brussels 17
Columbus 17
Nürnberg 17
Road Town 16
Phoenix 15
Salerno 15
San Diego 14
Atlanta 13
Brooklyn 13
London 13
Norwalk 13
Parma 13
Tokyo 13
Dong Ket 12
Montreal 12
Nuremberg 12
Orange 12
Pisa 12
Rio de Janeiro 12
Augusta 11
Palermo 11
Pavia 11
Perugia 11
Pune 11
Redondo Beach 11
Stockholm 11
Warsaw 11
Denver 10
Ningbo 10
Barcelona 9
Lodz 9
Marigliano 9
Washington 9
Auburn Hills 8
Goiânia 8
Manchester 8
Mumbai 8
Totale 137.849
Nome #
Formulation and characterization studies of trimethyl chitosan / sodium alginate nanoparticles for targeted drug delivery 4.627
From nanoemulsions to nanostructured lipid carriers: A relevant development in dermal delivery of drugs and cosmetics 4.179
Development of novel diolein-niosomes for cutaneous delivery of tretinoin: Influence of formulation and in vitro assessment 3.857
Phycocyanin-encapsulating hyalurosomes as carrier for skin delivery and protection from oxidative stress damage 3.656
Preparazione di nanoparticelle di TMC per il rilascio di farmaci a livello oculare 3.561
Preparation and characterization of TMC nanoparticles for colon specific drug delivery 3.533
Glycerosomes: use of hydrogenated soy phosphatidylcholine mixture and its effect on vesicle features and diclofenac skin penetration 3.514
Sintesi e caratterizzazione chimico-fisica di un derivato del chitosano per la realizzazione di sistemi nanoparticellari 3.486
Synthesis And Characterization Of A Chitosan Derivative For The Preparation Of Nanoparticles 3.293
PREPARATION OF TMC NANOPARTICLES FOR OCULAR DELIVERY 3.290
Physico-chemical characterization of succinyl chitosan-stabilized liposomes for the oral co-delivery of quercetin and resveratrol 3.049
Cavitation effect on chitosan nanoparticle size: A possible approach to protect drugs from ultrasonic stress 3.026
Glycerosomes: Investigation of role of 1,2-dimyristoyl-sn-glycero-3-phosphatidycholine (DMPC) on the assembling and skin delivery performances 3.009
Trimethyl chitosan hydrogel nanoparticles for progesterone delivery in neurodegenerative disorders 2.993
Potential therapeutic effect of curcumin loaded hyalurosomes against inflammatory and oxidative processes involved in the pathogenesis of rheumatoid arthritis: The use of fibroblast-like synovial cells cultured in synovial fluid 2.926
SINTESI DI TMC A DIVERSO GRADO DI QUATERNIZZAZIONE PER LA REALIZZAZIONE DI SISTEMI NANOPARTICELLARI 2.844
NANOPARTICELLE A BASE DI TMC E SA PER LA VEICOLAZIONE NOSE TO BRAIN 2.838
null 2.749
Composition influence on pulmonary delivery of rifampicin liposomes 2.736
PREPARAZIONE E CARATTERIZZAZIONE DI SISTEMI NANOPARTICELLARI DI TMC PER LA VEICOLAZIONE DI UN AGENTE ANTINFIAMMATORIO FITOTERAPICO MIRATO AL COLON 2.637
Preparazione e caratterizzazione di formulazioni cosmetiche contenenti olio di Neem 2.429
Nanoparticelle per la veicolazione nasale del Progesterone per il trattamento della malattia di Alzheimer 2.368
SYNTHESIS AND CHARACTERIZATION OF A CHITOSAN DERIVATIVE FOR THE PREPARATION OF NANOPARTICLES 2.347
Preparation and Characterization of TMC/SA nanoparticles for nose to brain drug delivery 2.317
BEADS DI CHITOSANO E SODIO ALGINATO: CARATTERISTICHE E PROPRIETÀ DI RILASCIO DI UN AGENTE FITOTERAPICO ANTINFIAMMATORIO 2.252
Approcci formulativi per ottimizzare l’incapsulazione nanoparticellare della Curcumina 2.189
null 2.150
SYNTHESIS OF COUMARIN -3-O-ACYLISOUREAS BY DICYCLOHEXYL CARBODIIMIDE 1.806
LIPOSOMI INCAPSULANTI E.S. DI UVA URSINA IN FORMULAZIONI COSMETICHE 1.767
null 1.580
null 1.507
null 1.415
Preservative systems containing essential oils in cosmetic products 1.410
Niosomi di triton CG 110 come carriers per l?8-metossipsoralene nelle patologie della pelle 1.380
Attività antivirale di liposomi contenenti l'olio essenziale di Santolina Insularis estratto con CO2 supercritica e in corrente di vapore 1.378
Cavitation Effect on Mean Diameter and Polydispersity Index of Chitosan Nanoparticles 1.317
Influence of polymeric system properties on the delivery of a phytoterapic anti-inflammatory agent 1.286
Stability studies of new cosmetic formulations with vegetable extracts as functional agents 1.285
null 1.267
Triton CG110 niosomes as carriers for the 8-methoxypsoralen in skin pathologies 1.219
Preparazione di nanoparticelle TMC/Alginato per la veicolazione al SNC 1.190
Sistemi polimerici veicolanti l’estratto di Boswellia Serrata 1.184
Liposome loaded herbal extracts to enhance skin-whitening activity 1.175
Chitosan beads loaded with essential oils in cosmetic formulations 1.148
Chitosan-beads loaded with Boswellia Serrata extract as phytoterapic anti-inflammatory agent 1.129
Physico-chemical stability of multilamellar liposomes entrapping caffeine 1.120
Chitosan and Protasan® Polymeric dispersions: Physical properties and effect on microparticle size 1.098
Phytotherapic anti-inflammatory agent delivery polymeric systems 1.010
Physical properties of chitosan dispersions in glycolic acid 1.001
null 987
Niosomi per la protezione degli agenti fotolabili 982
Studio di parametri fisici che intervengono nella realizzazione delle microsfere 950
Interfacial Phenomena Study in the Microspheres Production 940
Influence of rheological behaviour of polymeric matrices on the microsphere properties 930
Beads di chitosano incorporanti olii essenziali in formulazioni cosmetiche 915
Influenza dell'inclusione liposomiale sull'attività in vitro di miconazolo e ketoconazolo 915
Microparticles able to interfere on specific molecular targets involved in vascular proliferative diseases 908
Determinazione via GC/MS di bezafibrato, simvastatina e deidroepiandrosterone in sieri di ratti trattati con nitrato di piombo 905
MACROCYCLIC POLYETHER-DIESTER COMPOUNDS AS PHASE-TRANSFER CATALYSTS 876
Niosomi di triton CG110 per la veicolazione del 8-metossipsoralene 861
A CONVENIENT METHOD FOR THE SYNTHESIS OF MACROCYCLIC TETRAESTER COMPOUNDS. 848
Effetti dei liposomi sull'attività in vitro di alcuni antifungini 846
Preparazione di microsfere incapsulanti bezafibrato in grado di agire sul metabolismo lipidico 842
Phyisico-chemical stability of multilamellar liposomes entrapping caffeine 827
Vescicole fosfolipidiche quali carriers per l’alimentazione in acquacoltura 816
Assessment of the preserving activity of some essential oils in cosmetic products 810
?In vitro? release of liposomal caffeine: effects of polysorbates 778
STUDIES ON THE SYNTHESIS OF HETEROCYCLIC COMPOUNDS. XIII. THE SYNTHESIS OF MACROCYCLIC TETRAESTERS FROM 1,2-CYCLOHEXANE- AND 2,3-BUTANEDIOLS 767
STUDIES ON THE SYNTHESIS OF HETEROCYCLIC COMPOUNDS. XVI. CLEAVAGE OF 1,3-BENZODIOXOLES AND -BENZOXATHIOLES BY SODIUM IODIDE-ACYL CHLORIDE 762
null 739
null 733
CHANGES IN THE LIPOPROTEIN PATTERN IN G-6-PD DEFICIENT CHILDREN DURING HAEMOLYTIC CRISIS 732
null 724
MASS SPECTROMETRY AND CHEMICAL SYNTHESIS. THE CASE OF SOME SUBSTITUTED SPIRO [1,3-BENZODIOXOLE-2, 1′‐CYCLOHEXANES] 719
Rilascio di caffeina da strutture vescicolari 709
null 689
Studies on the synthesis of heterocyclic compounds. XIV. Cleavage of 1,3‐benzoxathioles by magnesium bromide‐acetic anhydride 686
null 675
SYNTHESIS AND PHARMACOLOGICAL PROPERTIES OF SOME AMIDES AND ESTERS OF 2,2-DIALKYL-1.3-BENZODIOXOLE-5--KETOBUTYRIC ACID 655
STUDIES ON THE SYNTHESIS OF HETEROCYCLIC COMPOUNDS. XVII. THE PREPARATION OF MACROCYCLIC POLYESTER LIGANDS CONTAINING THE 2,2'-BIS(HYDROXYMETHYL)DIPHENYLMETHANE SUBCYCLIC UNIT 634
MICONAZOLE, KETOCONAZOLE AND LIPOSOMAL PREPARATIONS: A REVERSED-PHASE HPLC DETERMINATION 630
null 623
Studi di stabilità di formulazioni cosmetiche funzionalizzate con estratti vegetali 619
Comparitive study of dissolution profiles in commercially available Aspirin tablets 612
null 607
null 605
null 586
Evaporation-freezing behaviour of chitosan dispersions in glycolic acid 550
Assessment of the preserving activity of some essential oils in cosmetic products 549
The role of Labrasol® in the enhancement of the cutaneous bioavailability of minoxidil in phospholipid Vesicles 543
Effetti della cavitazione ultrasonica sulle dimensioni e sulla distribuzione dimensionale di nanoparticelle 530
null 489
Formulazioni cosmetiche contenenti beads incapsulanti olio di Rosa mosqueta 360
Miconazole and ketoconazole in phospholipid formulations: in vitro antifungal activity 323
Effects of in-vitro activity of miconazole and ketoconazole in phospholipid formulations 288
Niosomi di Triton CG110 come carriers per l’8-metossipsoralene nelle patologie della pelle 242
Totale 143.843
Categoria #
all - tutte 176.017
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 176.017


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.834 0 0 0 373 434 386 237 323 456 503 514 608
2022/20237.852 665 966 979 721 554 627 409 809 443 676 692 311
2023/202411.802 422 1.454 638 1.238 1.195 1.801 1.246 703 682 527 952 944
2024/202512.490 1.891 2.911 2.303 1.597 865 844 1.167 109 182 167 209 245
2025/20265.314 340 202 492 319 320 475 691 387 338 1.014 368 368
2026/20271.559 113 267 846 333 0 0 0 0 0 0 0 0
Totale 143.843